Published in Medical Letter on the CDC and FDA, August 21st, 2005
Under the IND, Xsira intends to develop adenosine as an intraoperative infusion to reduce postoperative pain following surgery. Patient enrollment into a phase 2, multicenter clinical trial is expected to commence in the fall. Published clinical studies of adenosine in the surgical setting have been conducted under various physician-sponsored investigations in over 300 patients in the U.S. and abroad.
Pain in the immediate postoperative period remains a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA